Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 25.80%10.32B | 30.85%39.35B | 32.97%27.3B | 29.51%16.14B | 37.90%8.21B | 36.21%30.07B | 40.74%20.53B | 47.91%12.46B | 53.72%5.95B | 50.32%22.08B |
| Operating revenue | 25.80%10.32B | 30.85%39.35B | 32.97%27.3B | 29.51%16.14B | 37.90%8.21B | 36.21%30.07B | 40.74%20.53B | 47.91%12.46B | 53.72%5.95B | 50.32%22.08B |
| Other operating revenue | ---- | -1.80%42.61M | ---- | -3.18%15.82M | ---- | 22.41%43.4M | ---- | -11.96%16.34M | ---- | 20.77%35.45M |
| Total operating cost | 34.72%8.84B | 41.75%34.54B | 39.24%22.32B | 36.07%13.11B | 36.60%6.56B | 31.96%24.37B | 34.83%16.03B | 42.38%9.63B | 51.63%4.8B | 49.27%18.47B |
| Operating cost | 30.75%6.11B | 37.34%23.57B | 40.02%16B | 38.01%9.33B | 40.26%4.68B | 31.25%17.16B | 30.16%11.42B | 39.28%6.76B | 46.43%3.33B | 58.50%13.08B |
| Operating tax surcharges | 25.34%60.13M | 32.11%236.97M | 10.90%151.61M | 16.85%91.96M | 43.58%47.97M | 7.33%179.37M | 31.68%136.7M | 30.50%78.7M | 15.48%33.41M | 23.56%167.12M |
| Operating expense | 42.73%420.59M | 48.57%1.64B | 6.25%853.2M | -16.01%465.34M | 7.33%294.67M | 8.69%1.1B | 31.30%803.02M | 44.80%554.01M | 50.50%274.56M | 26.30%1.01B |
| Administration expense | 63.16%772.64M | 58.67%3.43B | 36.23%1.88B | 22.42%1.06B | 8.48%473.56M | 23.50%2.16B | 33.09%1.38B | 32.67%863.47M | 42.88%436.54M | 23.27%1.75B |
| Financial expense | 63.80%70.87M | 264.78%228.78M | 115.75%149.87M | 462.13%82.88M | 1,520.11%43.27M | 445.86%62.72M | 322.28%69.47M | 142.30%14.74M | -140.64%-3.05M | 78.16%-18.13M |
| -Interest expense (Financial expense) | 128.95%92.48M | 59.15%281.03M | 40.19%188.85M | 12.58%99.3M | -6.41%40.39M | 18.04%176.58M | 28.06%134.71M | 37.07%88.2M | 51.14%43.16M | 208.77%149.6M |
| -Interest Income (Financial expense) | 36.28%-18.3M | 46.34%-91.3M | 42.00%-72.15M | 44.97%-51.82M | 44.85%-28.72M | 2.78%-170.12M | 1.43%-124.39M | -19.57%-94.16M | -45.33%-52.07M | -17.34%-174.98M |
| Research and development | 36.64%1.4B | 46.96%5.44B | 48.40%3.29B | 52.74%2.08B | 40.89%1.03B | 49.42%3.7B | 59.41%2.21B | 59.69%1.36B | 98.58%728.48M | 34.14%2.48B |
| Credit Impairment Loss | -10.60%-56.42M | -1.67%-163.18M | -13.02%-207.43M | 5.47%-98.07M | 23.21%-51.02M | -103.12%-160.49M | -97.45%-183.54M | -38.16%-103.74M | -44.79%-66.44M | 7.17%-79.02M |
| Asset Impairment Loss | 553.82%17.02M | -104.83%-153.05M | -92.99%-13.2M | 60.03%-2.16M | -48.23%-3.75M | -260.35%-74.72M | -1,089.25%-6.84M | -536.50%-5.41M | -947.15%-2.53M | -14.90%-20.73M |
| Other net revenue | 93.99%312.66M | 18.07%990.9M | -46.35%295.89M | -30.92%290.52M | -32.46%161.18M | 0.63%839.23M | -17.39%551.5M | -13.21%420.53M | 817.65%238.64M | 51.62%833.99M |
| Fair value change income | ---2.45M | 40.99%8.83M | --11.35M | ---- | ---- | 209.08%6.26M | ---- | ---- | ---- | -122.98%-5.74M |
| Invest income | -2,357.15%-22.86M | -281.21%-5.89M | -1,165.15%-24.97M | -629.70%-7.8M | 19.16%1.01M | 138.73%3.25M | 90.15%2.34M | 80.09%1.47M | 65.52%850.05K | 196.20%1.36M |
| Net open hedge income | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Including: Investment income associates | 11.16%1.13M | -121.92%-530.13K | 243.84%8.06M | -65.33%510.69K | 19.16%1.01M | 77.46%2.42M | 90.15%2.34M | 80.09%1.47M | 65.52%850.05K | 196.20%1.36M |
| Exchange income | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Asset deal income | --429.35K | 128.07%11.15M | -68.97%1.59M | -73.53%233.13K | ---- | 287.74%4.89M | 9,136.00%5.12M | 1,488.34%880.67K | 10,974.96%751.24K | 77.41%-2.6M |
| Other revenue | 75.38%376.94M | 21.98%1.29B | -28.03%528.54M | -24.47%398.31M | -29.76%214.93M | 12.68%1.06B | -3.19%734.41M | -5.41%527.33M | 330.56%306.01M | 41.07%940.72M |
| Operating profit | -0.57%1.79B | -11.37%5.8B | 4.42%5.28B | 2.25%3.32B | 30.31%1.81B | 47.18%6.55B | 50.10%5.05B | 51.54%3.25B | 90.02%1.39B | 55.12%4.45B |
| Add:Non operating Income | 128.68%20.78M | 134.04%50.87M | 98.64%33.22M | 114.06%22.31M | 251.43%9.09M | -1.46%21.74M | 123.75%16.72M | 92.19%10.42M | 32.08%2.59M | 56.30%22.06M |
| Less:Non operating expense | -33.42%990.56K | -76.62%8.16M | -4.48%6.17M | 849.61%4.86M | 1,607.46%1.49M | 696.56%34.92M | 1,304.62%6.46M | 737.19%511.5K | 1,631.56%87.14K | -83.82%4.38M |
| Total profit | 0.10%1.81B | -10.53%5.85B | 4.74%5.3B | 2.48%3.34B | 30.62%1.81B | 46.30%6.53B | 50.09%5.06B | 51.63%3.26B | 89.85%1.39B | 56.44%4.47B |
| Less:Income tax cost | 0.63%246.74M | -46.75%436.21M | -44.24%322.71M | -68.23%138.73M | 12.56%245.2M | 89.23%819.12M | 45.13%578.76M | 49.87%436.68M | 88.25%217.84M | 38.08%432.86M |
| Net profit | 0.02%1.57B | -5.34%5.41B | 11.06%4.98B | 13.42%3.2B | 33.98%1.57B | 41.69%5.71B | 50.75%4.48B | 51.90%2.82B | 90.15%1.17B | 58.71%4.03B |
| Net profit from continuing operation | 0.02%1.57B | -5.34%5.41B | 11.06%4.98B | 13.42%3.2B | 34.01%1.57B | 41.69%5.71B | 50.75%4.48B | 51.90%2.82B | 90.11%1.17B | 58.71%4.03B |
| Net income from discontinuing operating | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Less:Minority Profit | -409.77%-66.78M | -222.45%-113.09M | -1,011.23%-150.11M | -121.02%-6.78M | -141.97%-13.1M | -30.90%92.35M | -81.77%16.47M | -45.23%32.25M | 32.12%31.22M | -29.01%133.65M |
| Net profit of parent company owners | 3.42%1.63B | -1.77%5.52B | 14.83%5.13B | 14.97%3.21B | 38.80%1.58B | 44.18%5.62B | 54.90%4.47B | 55.08%2.79B | 92.47%1.14B | 65.73%3.9B |
| Earning per share | ||||||||||
| Basic earning per share | 2.83%2.2556 | -2.40%7.6446 | 14.10%7.1093 | 14.23%4.4496 | 2.14%2.1935 | 6.38%7.8322 | 14.38%6.231 | 14.56%3.8952 | 92.01%2.1476 | 65.03%7.3623 |
| Diluted earning per share | 2.81%2.2549 | -2.38%7.6404 | 14.23%7.1016 | 14.29%4.4479 | 2.13%2.1933 | 6.68%7.8263 | 14.44%6.2172 | 14.55%3.8918 | 92.13%2.1476 | 64.91%7.3362 |
| Other composite income | -935.83%-6.15M | -667.56%-43.54M | 197.15%2.07M | -107.26%-81.99K | -219.20%-593.66K | 11.08%7.67M | -163.24%-2.14M | -84.03%1.13M | 106.73%498.04K | 91.03%6.91M |
| Other composite income of parent company owners | -852.94%-5.66M | -1,205.28%-41.92M | 206.15%2.27M | -101.84%-20.82K | -219.20%-593.66K | -45.08%3.79M | -163.24%-2.14M | -84.03%1.13M | 106.73%498.04K | 91.03%6.91M |
| Other composite income of minority owners | ---492.09K | -141.74%-1.62M | ---192.13K | ---61.17K | ---- | --3.88M | ---- | ---- | --0 | ---- |
| Total composite income | -0.33%1.56B | -6.23%5.37B | 11.16%4.98B | 13.37%3.2B | 33.87%1.57B | 41.64%5.72B | 50.51%4.48B | 51.39%2.82B | 92.55%1.17B | 58.75%4.04B |
| Total composite income of parent company owners | 3.10%1.63B | -2.59%5.48B | 14.94%5.13B | 14.92%3.21B | 38.69%1.58B | 44.02%5.63B | 54.65%4.47B | 54.54%2.79B | 94.99%1.14B | 65.76%3.91B |
| Total composite income of minority owners | -413.52%-67.27M | -219.20%-114.7M | -1,012.39%-150.3M | -121.21%-6.84M | -141.97%-13.1M | -28.00%96.23M | -81.77%16.47M | -45.23%32.25M | 32.12%31.22M | -29.01%133.65M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianzhi International Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.